Heritage Investors Management Corp Has $600,000 Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Heritage Investors Management Corp cut its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,675 shares of the company’s stock after selling 334 shares during the quarter. Heritage Investors Management Corp’s holdings in GE HealthCare Technologies were worth $600,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of GEHC. Assenagon Asset Management S.A. grew its stake in GE HealthCare Technologies by 10.1% in the 3rd quarter. Assenagon Asset Management S.A. now owns 13,735 shares of the company’s stock valued at $1,289,000 after buying an additional 1,256 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in GE HealthCare Technologies by 2.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 76,349 shares of the company’s stock valued at $7,165,000 after buying an additional 1,920 shares during the last quarter. Valmark Advisers Inc. acquired a new stake in GE HealthCare Technologies in the 3rd quarter worth $222,000. Golden State Equity Partners acquired a new stake in GE HealthCare Technologies in the 3rd quarter worth $532,000. Finally, Folger Nolan Fleming Douglas Capital Management Inc. acquired a new stake in GE HealthCare Technologies in the 3rd quarter worth $221,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on GEHC. Citigroup raised their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Wells Fargo & Company raised their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. One research analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $97.67.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $89.40 on Friday. The company has a 50-day moving average of $86.00 and a 200-day moving average of $86.07. The company has a market capitalization of $40.88 billion, a price-to-earnings ratio of 20.65, a PEG ratio of 3.19 and a beta of 1.15. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.